Afexa

Valeant Fighting Class-Action Application for Cold-fX Lawsuit

The makers of Cold-fX are in court fighting allegations they ignored their own research and misled consumers about the short-term effectiveness of the popular cold and flu remedy. Valeant Pharmaceuticals was in British Columbia Supreme Court on Monday, opposing an application to grant the lawsuit class-action status. Vancouver Island resident Don Harrison launched a claim in 2012 against …